Investor Inquiry
The current position: Home>Investor Relations>Investor Inquiry

Charmacy Pharmaceutical Co., Ltd.

Address: No.235, North Songshan Road, Longhu District, Shantou, P.R.China
Phone /TEL:0754-88109272

Zip /P.C.: 515041

Financial PR Company

Zhixin Investor Relations Consultant Limited

Address: Room2402,Kingkey Timemark Building,9289 Binhe Avenue,Futian District,Shenzhen,P.R.China

Tel: 0755-25896809



Pursuant to the Rules Governing the Listingof Securities on The Stock Exchange of Hong Kong Limited, the Company hasadopted electronic dissemination of Corporate Communications to disseminatesand publishes Corporate Communications to the shareholders of the Company on the Company's website at and the HKEXnews website at


"Corporate Communication" meansany document issued or to be issued by the Company for the information oraction by any of its shareholders, including but not limited to (a) thedirectors’ report, its annual accounts together with a copy of the auditors’report and, where applicable, its summary financial report; (b) the interim reportand, where applicable, its summary interim report; (c) a notice of meeting; (d)a listing document; (e) a circular and (f) a proxy form.


The reply form for registered shareholders and non-registered shareholders ofthe Company to select the method of receiving Actionable CorporateCommunications and/or request printed copies can be downloaded through thefollowing links:


-Notification letter and reply form for arrangement of electronicdissemination of Corporate Communications for registered shareholders


-Notification letter and reply form for arrangement of electronicdissemination of Corporate Communications for non-registered shareholders


At the same time, shareholders can alsodownload the above notification letter and replyform from the HKEXnews website.


If the shareholder has provided his or hervalid email address, the shareholder will receive Actionable CorporateCommunications by email each time theCompany publishes Actionable CorporateCommunication. If shareholders wish to receive Corporate Communications inprinted form, please fill in and submit the above reply form to the Company's share registrar, or send an email to by specifying the shareholder's name, addressand request to receive the Corporate Communications in printed form. Pleasenote that instruction to receive future Corporate Communications in printedform will be valid for one year from the receipt date of the shareholder'sinstruction and will expire thereafter.

The Enterprise OA